Cowealth Medical Holding Co (ROCO:4745) Beneish M-Score: -2.10 (As of Jul. 13, 2026)


ROCO:4745 Cowealth Medical Holding Co Ltd ROCO:4745
50 GF Score
Price NT$13.80
GF Value NT$13.11
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Cowealth Medical Holding Co Beneish M-Score?

Cowealth Medical Holding Co ROCO:4745 50 Beneish M-Score is -2.10 as of Jul. 13, 2026. GuruFocus rates ROCO:4745 with a GF Score™ of 50/100 and a GF Value™ of NT$13.11 (Fairly Valued). The stock has 6 warning signs investors should review. Among 763 Medical Devices & Instruments companies, Cowealth Medical Holding Co ranks worse than 77.72% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.1 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Cowealth Medical Holding Co's Beneish M-Score or its related term are showing as below:

ROCO:4745' s Beneish M-Score Range Over the Past 10 Years
Min: -3.06   Med: -2.26   Max: -1.85
Current: -2.1

During the past 13 years, the highest Beneish M-Score of Cowealth Medical Holding Co was -1.85. The lowest was -3.06. And the median was -2.26.


Cowealth Medical Holding Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Cowealth Medical Holding Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cowealth Medical Holding Co Beneish M-Score Chart

Cowealth Medical Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.16 -1.85 -2.36 -2.74 -2.10

Cowealth Medical Holding Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.74 -2.80 -3.49 -3.25 -2.10

ROCO:4745 vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Cowealth Medical Holding Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cowealth Medical Holding Co Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cowealth Medical Holding Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Cowealth Medical Holding Co's Beneish M-Score falls into.


ROCO:4745
50GF Score
Cowealth Medical Holding Co Ltd ROCO:4745
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cowealth Medical Holding Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Cowealth Medical Holding Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3437+0.528 * 1.4231+0.404 * 1.7787+0.892 * 0.7051+0.115 * 1.2677
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1515+4.679 * -0.037217-0.327 * 1.1157
=-2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was NT$3,219 Mil.
Revenue was 571.89 + 771.546 + 818.501 + 794.32 = NT$2,956 Mil.
Gross Profit was 31.128 + 115.953 + 119.193 + 125.902 = NT$392 Mil.
Total Current Assets was NT$5,513 Mil.
Total Assets was NT$7,042 Mil.
Property, Plant and Equipment(Net PPE) was NT$692 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$50 Mil.
Selling, General, & Admin. Expense(SGA) was NT$555 Mil.
Total Current Liabilities was NT$1,975 Mil.
Long-Term Debt & Capital Lease Obligation was NT$9 Mil.
Net Income was -160.682 + -31.87 + -23.539 + -30.466 = NT$-247 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was -481.14 + -85.864 + 508.134 + 74.4 = NT$16 Mil.
Total Receivables was NT$3,397 Mil.
Revenue was 1024.373 + 1037.821 + 1084.282 + 1046.246 = NT$4,193 Mil.
Gross Profit was 173.489 + 191.978 + 197.617 + 228.437 = NT$792 Mil.
Total Current Assets was NT$5,949 Mil.
Total Assets was NT$6,958 Mil.
Property, Plant and Equipment(Net PPE) was NT$545 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$51 Mil.
Selling, General, & Admin. Expense(SGA) was NT$684 Mil.
Total Current Liabilities was NT$1,753 Mil.
Long-Term Debt & Capital Lease Obligation was NT$4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3218.805 / 2956.257) / (3397.338 / 4192.722)
=1.088811 / 0.810294
=1.3437

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(791.521 / 4192.722) / (392.176 / 2956.257)
=0.188785 / 0.13266
=1.4231

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5513.051 + 692.497) / 7042.105) / (1 - (5948.722 + 544.978) / 6958.441)
=0.118794 / 0.066788
=1.7787

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2956.257 / 4192.722
=0.7051

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(50.945 / (50.945 + 544.978)) / (50.076 / (50.076 + 692.497))
=0.085489 / 0.067436
=1.2677

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(555.178 / 2956.257) / (683.781 / 4192.722)
=0.187798 / 0.163088
=1.1515

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((9.069 + 1974.743) / 7042.105) / ((3.526 + 1753.431) / 6958.441)
=0.281707 / 0.252493
=1.1157

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-246.557 - 0 - 15.53) / 7042.105
=-0.037217

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Cowealth Medical Holding Co has a M-score of -2.10 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.10 mean?
Cowealth Medical Holding Co (ROCO:4745) has a Beneish M-Score of -2.10 as of Jul. 13, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Cowealth Medical Holding Co and its competitors. According to the industry distribution chart, Cowealth Medical Holding Co ranks #593 out of 763 companies in the Medical Devices & Instruments industry, placing it in the top 77.7%.
Is Cowealth Medical Holding Co's Beneish M-Score too high?
Cowealth Medical Holding Co's current Beneish M-Score is -2.10. Based on the distribution chart, Cowealth Medical Holding Co ranks #593 out of 763 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cowealth Medical Holding Co has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cowealth Medical Holding Co ranks #593 out of 763 companies for Beneish M-Score. This places Cowealth Medical Holding Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Cowealth Medical Holding Co and its competitors. Cowealth Medical Holding Co's current Beneish M-Score is -2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.11, compared to a current price of NT$13.80 — trading 5.3% above its estimated fair value. The current Beneish M-Score is -2.10. Cowealth Medical Holding Co's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current Beneish M-Score is -2.10 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?

Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be overvalued. The current stock price of NT$13.80 is trading 5.3% above its estimated GF Value™ of NT$13.11. GuruFocus considers Cowealth Medical Holding Co to be Fairly Valued.

Key valuation signals for ROCO:4745:

  • Beneish M-Score: -2.10
  • GF Value™: NT$13.11 vs. price of NT$13.80 (5.3% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cowealth Medical Holding Co Business Description

Address North Sound Road, Suite 102, Cannon Place, P.O. Box 712, George Town, Grand Cayman, CYM, KY1-9006
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
50GF Score

Get the complete analysis for ROCO:4745

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.80
Price
NT$13.11
GF Value